Top

Published in:

01-04-2022 | Bronchial Asthma | CE-Research Letter to the Editor

Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization

Authors: Maurizio Gabrielli, Giulia Pignataro, Marcello Candelli, Marta Sacco Fernandez, Martina Bizzarri, Alessandra Esperide, Francesco Franceschi, GEMELLI AGAINST COVID 2019

Published in: Internal and Emergency Medicine | Issue 3/2022

Excerpt

Dear Editor, …

Liu S, Cao Y, Du T, Zhi Y (2021) Prevalence of comorbid asthma and related outcomes in COVID-19: a systematic review and meta-analysis. J Allergy Clin Immunol Pract 2:693–701. https://doi.org/10.1016/j.jaip.2020.11.054CrossRef

Mendes NF, Jara CP, Mansour E, Araújo EP, Velloso LA (2021) Asthma and COVID-19: a systematic review. Allergy Asthma Clin Immunol 17:5. https://doi.org/10.1186/s13223-020-00509-yCrossRefPubMedPubMedCentral

Sunjaya AP, Allida SM, Di Tanna GL, Jenkins C (2021) Asthma and risk of infection, hospitalization, ICU admission and mortality from COVID-19: systematic review and meta-analysis. J Asthma. https://doi.org/10.1080/02770903.2021.1888116CrossRefPubMedPubMedCentral

Wang Y, Chen J, Chen W, Liu L, Dong M, Ji J, Hu D, Zhang N (2021) Does asthma increase the mortality of patients with COVID-19? A systematic review and meta-analysis. Int Arch Allergy Immunol 182:76–82. https://doi.org/10.1159/000510953CrossRefPubMed

Wu T, Yu P, Li Y, Wang J, Li Z, Qiu J, Cui L, Mou Y, Sun Y (2021) Asthma does not influence the severity of COVID-19: a meta-analysis. J Asthma 23:1–7. https://doi.org/10.1080/02770903.2021.1917603CrossRef

Izquierdo JL, Almonacid C, González Y, Del Rio-Bermudez C, Ancochea J, Cárdenas R, Lumbreras S, Soriano JB (2021) The impact of COVID-19 on patients with asthma. Eur Respir J 57:2003142. https://doi.org/10.1183/13993003.03142-2020CrossRefPubMedPubMedCentral

Robinson LB, Wang L, Fu X, Wallace ZS, Long AA, Zhang Y, Camargo CA Jr, Blumenthal KG (2021) COVID-19 severity in asthma patients: a multi-center matched cohort study. J Asthma. https://doi.org/10.1080/02770903.2020.1857396CrossRefPubMedPubMedCentral

Cao L, Lee S, Krings JG, Rauseo AM, Reynolds D, Presti R, Goss C, Mudd PA, O’Halloran JA, Wang L (2021) Asthma in patients with suspected and diagnosed coronavirus disease 2019. Ann Allergy Asthma Immunol 126:535–541. https://doi.org/10.1016/j.anai.2021.02.020CrossRefPubMedPubMedCentral

Cricelli C, Brignoli O, Medea G, Parretti D, Lombardo FP, Lora Aprile P, Lapi F, Cricelli IC (2021) Impatto epidemiologico delle cronicità in Medicina Generale,” Rapporto Osservasalute 2020; 1:137–163. file:///C:/Users/00104240/Downloads/RO-2020-cronicit%C3%A0.pdf

10.

Caminati M, Vultaggio A, Matucci A, Senna G, Almerigogna F, Bagnasco D, Chieco-Bianchi F, Cosini F, Girelli D, Guarnieri G, Menzella F, Micheletto C, Olivieri O, Passalacqua G, Pini L, Rossi O, Vianello A, Vivarelli E, Crisafulli E (2021) Asthma in a large COVID-19 cohort: prevalence, features, and determinants of COVID-19 disease severity. Respir Med 176:106261. https://doi.org/10.1016/j.rmed.2020.106261CrossRefPubMed

11.

Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA, Drosten C, Pöhlmann S (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271-280.e8. https://doi.org/10.1016/j.cell.2020.02.052CrossRefPubMedPubMedCentral

12.

Peters MC, Sajuthi S, Deford P, Christenson S, Rios CL, Montgomery MT, Woodruff PG, Mauger DT, Erzurum SC, Johansson MW, Denlinger LC, Jarjour NN, Castro M, Hastie AT, Moore W, Ortega VE, Bleecker ER, Wenzel SE, Israel E, Levy BD, Seibold MA, Fahy JV, COVID-19-related Genes in Sputum Cells in Asthma (2020) Relationship to demographic features and corticosteroids. Am J Respir Crit Care Med 202(1):83–90. https://doi.org/10.1164/rccm.202003-0821OC (Erratum in: Am J Respir Crit Care Med. 2020; 202(12):1744–1746)CrossRefPubMedPubMedCentral

13.

Maes T, Bracke K, Brusselle GG (2020) COVID-19, asthma, and Inhaled corticosteroids: another beneficial effect of inhaled corticosteroids? Am J Respir Crit Care Med 202:8–10. https://doi.org/10.1164/rccmCrossRefPubMedPubMedCentral

14.

Liu S, Zhi Y, Ying S (2020) COVID-19 and asthma: reflection during the pandemic. Clin Rev Allergy Immunol 59:78–88. https://doi.org/10.1007/s12016-020-08797-3CrossRefPubMedPubMedCentral

Title: Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization
Authors: Maurizio Gabrielli
Giulia Pignataro
Marcello Candelli
Marta Sacco Fernandez
Martina Bizzarri
Alessandra Esperide
Francesco Franceschi
GEMELLI AGAINST COVID 2019
Publication date: 01-04-2022
Publisher: Springer International Publishing
Keywords: Bronchial Asthma
COVID-19
Published in: Internal and Emergency Medicine / Issue 3/2022
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-021-02868-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2022

Prevalence and duration of symptoms among moderate and severe COVID-19 patients 12 months after discharge

Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry

Communication and relationship at time of COVID-19: a possible heritage

Different rates of conjunctivitis in COVID-19 eastern and western hospitalized patients: a meta-analysis

Overdiagnosis in the emergency department: a sharper focus

Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage